'Coronil An Evidence-Based Medicine With Scientifically Validated Research': Patanjali Counters IMA's Scathing Attack
Acharya Balkrishna, General Secretary of Patanjali Research Foundation Trust, Haridwar said today (24 February) that the health minister Dr Harsh Vardhan didn't endorse any ayurvedic medicine, neither, did he undermine the modern medicines.
This statement came after a controversy over Union Health Minister Dr Harsh Vardhan and Union Minister Nitin Gadkari attending a 19 February event in Delhi in which Yoga Guru Ramdev released 'the first evidence-based medicine’ for COVID-19 by Patanjali.
The Health Minister in that event had said that there is a Rs 30,000 crore Ayurveda driven economy in India.
As per official data, prior to the Covid-19 pandemic, Ayurveda used to see a growth of 15-20 per cent every year, which has risen to 50-90 per cent. It's an indication that people have accepted it. There is a marked improvement in exports and FDI.
After the event, Indian Medical Association, a voluntary body of private practitioners of modern medicine, expressed “shock” and “dismay” at what it called is a “blatant lie of WHO certification” for Patanjali’s Coronil tablet.
It also demanded an explanation from Health Minister Harsh Vardhan about his presence at the event where Coronil was launched last week.
In response, Acharya Balkrishna, General Secretary, Patanjali Research Foundation Trust's statement expresses regret on the “lack of understanding of the scientific research concepts.
The statement elaborated on the scientific credentials of the Coronil tablet and said that all the studies on the effectiveness were published in peer-reviewed journals.
The statement said that Coronil “has been validated through in-vitro in-vivo biological and chemical studies along with Randomised Controlled Trials (RCTs).”
“These studies have been conducted by following rigorous norms and regulations for biological and clinical research,” the statement reads.
It further lists research publications on the subject and says that there are 18 more publications in the pipeline.
“Coronil is an evidence-based medicine with integration of scientifically validated research evidences under pre-clinical and clinical expertise. The composition of this medicine has been revealed to the public at large, and has been thoroughly reviewed and scrutinised by competent authorities.”
“.. the contents of Coronil are clearly described on the packing, as per the regulatory requirements. Therefore, Coronil is no way a secret medicine as described by IMA officials..”
The release also gave the research publication for the randomised, placebo-controlled, double-blinded clinical trial on the COVID-19 patients.
It further stated that Dr Harsh Vardhan hadn't endorsed any ayurvedic medicine, neither, did he undermine the modern medicines. “He has done what a Health Minister should do: raise awareness of his countrymen in the face of a persistent crisis. We believe there is nothing unethical about it”.
The Indian Medical Association is often accused of advocating for the interest of big private hospitals over the common good.
Delhi Medical Association on Monday slammed the IMA for defaming and making baseless comments on Union Health Minister Dr Harsh Vardhan and Patanjali's 'Coronil'.
In a statement it said that “IMA has fabricated the facts to make a sensational case against the health minister only to achieve cheap publicity by abusing a sincere dedicated and honest member of IMA who has brought laurels to the whole medical community by occupying the position of the union minister of health by his sheer hard work, sincerity and integrity”.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.